Oxytocin Injection Market

Oxytocin Injection Market contains market size and forecasts of Oxytocin Injection in global, including the following market information:

• Global Oxytocin Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Oxytocin Injection Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Oxytocin Injection companies in 2021 (%)

The global Oxytocin Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oxytocin Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Oxytocin Injection include JHP Pharmaceuticals, Grindex, Pfizer, Novartis, GSK, Bimeda, Bayer, Agrilab and Kepro B.V., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Oxytocin Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Oxytocin Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Oxytocin Injection Market Segment Percentages, by Type, 2021 (%)

• Oxytocin
• Carbetocin

Global Oxytocin Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Oxytocin Injection Market Segment Percentages, by Application, 2021 (%)

• Animal Use
• Human Use

Global Oxytocin Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Oxytocin Injection Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Oxytocin Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Oxytocin Injection revenues share in global market, 2021 (%)
• Key companies Oxytocin Injection sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Oxytocin Injection sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• JHP Pharmaceuticals
• Grindex
• Pfizer
• Novartis
• GSK
• Bimeda
• Bayer
• Agrilab
• Kepro B.V.
• Hybio Pharmaceutical
• Shanghai Hefeng
• Renjian Pharmaceutical